These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2406919)

  • 1. Chemotherapy for large cell lymphoma: a status update.
    Yi PI; Coleman M; Saltz L; Norton L; Topilow AA; Adler K; Bernhardt B
    Semin Oncol; 1990 Feb; 17(1):60-73. PubMed ID: 2406919
    [No Abstract]   [Full Text] [Related]  

  • 2. [Malignant lymphoma].
    Mori T
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):162-6. PubMed ID: 17301521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study on advanced non-Hodgkin's lymphoma with special reference to the results of chemotherapies with ACOP, ACOP-E and AclBEP regimen].
    Nakamura S; Yoshida T; Ohtake S; Itoh K; Kobayashi K; Kanno M; Hirai J; Tachimori K; Matsuda T; Saito Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1176-84. PubMed ID: 3430011
    [No Abstract]   [Full Text] [Related]  

  • 4. Initial chemotherapy with an age-adjusted CHOP-schedule in non-Hodgkin lymphomas with unfavorable prognosis. A study of the I.G.C.I.
    Heinz R; Pawlicki M; Losonczy H; Varbiro M; Benedek S; Konopka L; Krc I; Brugiatelli M
    Haematologica; 1986; 71(6):473-9. PubMed ID: 3104156
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-Hodgkin lymphoma of the prostate.
    Steuter J; Weisenburger DD; Bociek RG; Bierman P; Vose J; Bast M; Loberiza F; Armitage JO
    Am J Hematol; 2011 Nov; 86(11):952-4. PubMed ID: 21898531
    [No Abstract]   [Full Text] [Related]  

  • 6. Infusional chemotherapy for non-Hodgkin's lymphoma.
    Molldrem J; Wilson WH
    Cancer Invest; 1997; 15(5):465-74. PubMed ID: 9316629
    [No Abstract]   [Full Text] [Related]  

  • 7. [Resistance avoided, prognosis improved--myocet in AIDS-related non-Hodgkin's lymphoma].
    Pohlmann BK
    Onkologie; 2004 Oct; 27(5):514-5. PubMed ID: 15595188
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of treatment in children with diffuse large cell lymphoma].
    Okamura J; Ikuno Y; Yamada S; Tasaka H; Nibu K; Ikeda N; Kikuchi M
    Rinsho Ketsueki; 1987 Aug; 28(8):1365-9. PubMed ID: 3430752
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
    Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
    Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
    [No Abstract]   [Full Text] [Related]  

  • 10. [Malignant lymphoma: individualized treatment according to biological and clinical risk factors].
    Dreyling M
    Dtsch Med Wochenschr; 2011 Apr; 136(14):687-90. PubMed ID: 21448827
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized study comparing yttrium-90 ibritumomab tiuxetan (Zevalin) and high-dose BEAM chemotherapy versus BEAM alone as the conditioning regimen before autologous stem cell transplantation in patients with aggressive lymphoma.
    Shimoni A; Avivi I; Rowe JM; Yeshurun M; Levi I; Or R; Patachenko P; Avigdor A; Zwas T; Nagler A
    Cancer; 2012 Oct; 118(19):4706-14. PubMed ID: 22252613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
    Spina M; Simonelli C; Tirelli U
    J Clin Oncol; 2007 Feb; 25(6):e7. PubMed ID: 17308261
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of non-Hodgkin lymphoma in elderly patients].
    Salminen E
    Duodecim; 1994; 110(21):1993-8. PubMed ID: 8654224
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of combination chemotherapy with adriamycin in elderly non-Hodgkin's lymphoma patients].
    Takenaka T; Konda C; Sakano T; Kitahara T; Minato K; Tobinai K; Shimoyama M
    Rinsho Ketsueki; 1988 Feb; 29(2):161-6. PubMed ID: 3385943
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alternating non-cross resistant multi-drug chemotherapy against malignant lymphoma (CAMBO-VIP)--consideration of the dose intensity].
    Hirano M; Okamoto M; Maruyama F; Shinkai K; Miyazaki H; Ezaki K
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):1982-8. PubMed ID: 2221923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adult non-hodgkin lymphoma: Has high-dose chemotherapy improved the prognosis?].
    Hiddemann W
    Dtsch Med Wochenschr; 2011 Nov; 136(45):2293. PubMed ID: 22052589
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current status of chemotherapy in the treatment of malignant lymphomas].
    Ohnoshi T; Hayashi K; Ueno K; Tada A; Murashima M; Mizuta J; Tagawa S; Kimura I
    Gan To Kagaku Ryoho; 1989 May; 16(5):1989-96. PubMed ID: 2658838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of malignant lymphoma].
    Shimoyama M
    Gan No Rinsho; 1989 Jan; Spec No():593-604. PubMed ID: 2783748
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of lymphoma in the aged].
    Gómez H; Colomer R
    Med Clin (Barc); 1998 May; 110(15):574-5. PubMed ID: 9650201
    [No Abstract]   [Full Text] [Related]  

  • 20. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
    Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K
    Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.